DK1137797T3 - Ekspressionssystem for faktor VIII - Google Patents
Ekspressionssystem for faktor VIIIInfo
- Publication number
- DK1137797T3 DK1137797T3 DK99966068T DK99966068T DK1137797T3 DK 1137797 T3 DK1137797 T3 DK 1137797T3 DK 99966068 T DK99966068 T DK 99966068T DK 99966068 T DK99966068 T DK 99966068T DK 1137797 T3 DK1137797 T3 DK 1137797T3
- Authority
- DK
- Denmark
- Prior art keywords
- factor viii
- expression system
- viii expression
- glycosylated
- linked
- Prior art date
Links
- 102000001690 Factor VIII Human genes 0.000 title 1
- 108010054218 Factor VIII Proteins 0.000 title 1
- 229960000301 factor viii Drugs 0.000 title 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical compound OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 abstract 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 abstract 1
- 102000035122 glycosylated proteins Human genes 0.000 abstract 1
- 108091005608 glycosylated proteins Proteins 0.000 abstract 1
- 102000057593 human F8 Human genes 0.000 abstract 1
- 229960000900 human factor viii Drugs 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/209,916 US6358703B1 (en) | 1998-12-10 | 1998-12-10 | Expression system for factor VIII |
| PCT/US1999/029169 WO2000034505A1 (en) | 1998-12-10 | 1999-12-08 | Expression system for factor viii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1137797T3 true DK1137797T3 (da) | 2009-02-23 |
Family
ID=22780858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99966068T DK1137797T3 (da) | 1998-12-10 | 1999-12-08 | Ekspressionssystem for faktor VIII |
Country Status (26)
| Country | Link |
|---|---|
| US (10) | US6358703B1 (https=) |
| EP (1) | EP1137797B1 (https=) |
| JP (1) | JP4240818B2 (https=) |
| KR (1) | KR100616028B1 (https=) |
| AT (1) | ATE412765T1 (https=) |
| AU (1) | AU761801B2 (https=) |
| BG (1) | BG65431B1 (https=) |
| BR (1) | BRPI9916069B8 (https=) |
| CA (1) | CA2354845C (https=) |
| CZ (1) | CZ302330B6 (https=) |
| DE (1) | DE69939839D1 (https=) |
| DK (1) | DK1137797T3 (https=) |
| ES (1) | ES2315026T3 (https=) |
| HU (1) | HU228489B1 (https=) |
| IL (2) | IL143353A0 (https=) |
| NO (1) | NO329544B1 (https=) |
| NZ (1) | NZ512234A (https=) |
| PL (1) | PL200676B1 (https=) |
| PT (1) | PT1137797E (https=) |
| RO (1) | RO121604B1 (https=) |
| RU (1) | RU2249041C2 (https=) |
| SI (1) | SI20644B (https=) |
| SK (1) | SK286945B6 (https=) |
| TR (1) | TR200101592T2 (https=) |
| UA (1) | UA77383C2 (https=) |
| WO (1) | WO2000034505A1 (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6475725B1 (en) | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
| US6180108B1 (en) * | 1998-12-10 | 2001-01-30 | Bayer Corporation | Vectors having terminal repeat sequence of Epstein-Barr virus |
| US6358703B1 (en) | 1998-12-10 | 2002-03-19 | Bayer Corporation | Expression system for factor VIII |
| KR100581574B1 (ko) * | 2000-03-22 | 2006-05-22 | 옥타게네 게엠베하 | 인간 세포주 내 재조합 혈액 응고 인자의 제조 |
| US7205278B2 (en) * | 2001-06-14 | 2007-04-17 | The Scripps Research Institute | Stabilized proteins with engineered disulfide bonds |
| WO2004075923A2 (en) * | 2003-02-26 | 2004-09-10 | Nektar Therapeutics Al, Corporation | Polymer-factor viii moiety conjugates |
| US7485291B2 (en) * | 2003-06-03 | 2009-02-03 | Cell Genesys, Inc. | Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| WO2005017149A1 (en) * | 2003-06-03 | 2005-02-24 | Cell Genesys, Inc. | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| EP1812557A4 (en) * | 2004-10-29 | 2009-11-04 | Centocor Ortho Biotech Inc | COMPOSITIONS OF CHEMICALLY DEFINED MEDIA |
| KR101468345B1 (ko) * | 2004-11-12 | 2014-12-03 | 바이엘 헬스케어 엘엘씨 | Ｆｖｉｉｉ의 부위 지향 변형 |
| AR058568A1 (es) | 2005-12-20 | 2008-02-13 | Bristol Myers Squibb Co | Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo |
| EP2253644B1 (en) | 2005-12-20 | 2013-10-16 | Bristol-Myers Squibb Company | Compositions and methods for producing a composition |
| PL2235197T3 (pl) | 2007-12-27 | 2018-01-31 | Baxalta GmbH | Sposoby hodowli komórek |
| KR101005967B1 (ko) | 2008-04-12 | 2011-01-05 | (주)셀트리온 | 우수한 재조합 단백질을 생산하기 위한 인간 숙주 세포 |
| KR20110033242A (ko) * | 2008-06-25 | 2011-03-30 | 바이엘 헬스케어 엘엘씨 | 면역원성이 감소된, 인자 ⅷ 뮤테인 |
| CN102119172A (zh) | 2008-08-21 | 2011-07-06 | 奥克塔法马股份有限公司 | 重组制备的人类因子viii和ix |
| US20110178019A1 (en) * | 2008-09-03 | 2011-07-21 | Brita Rippner | New protecting compositions for recombinantly produced factor viii |
| CA2748314C (en) | 2009-02-03 | 2018-10-02 | Amunix Operating Inc. | Extended recombinant polypeptides and compositions comprising same |
| WO2010111414A1 (en) * | 2009-03-24 | 2010-09-30 | Bayer Healthcare Llc | Factor viii variants and methods of use |
| AU2010290131C1 (en) | 2009-08-24 | 2015-12-03 | Amunix Operating Inc. | Coagulation factor VII compositions and methods of making and using same |
| US20110150843A1 (en) * | 2009-10-30 | 2011-06-23 | National Institute Of Immunology | Method for the therapeutic correction of hemophilia a by transplanting bone marrow cells |
| US20130017997A1 (en) * | 2010-08-19 | 2013-01-17 | Amunix Operating Inc. | Factor VIII Compositions and Methods of Making and Using Same |
| RU2600886C2 (ru) * | 2011-05-13 | 2016-10-27 | Октафарма Аг | Способ повышения продуктивности эукариотических клеток в продуцировании рекомбинантного fviii |
| DK2804623T3 (da) | 2012-01-12 | 2019-11-11 | Bioverativ Therapeutics Inc | Kimære faktor viii-polypeptider og anvendelser deraf |
| BR112014020694A2 (pt) | 2012-02-15 | 2018-05-08 | Amunix Operating Inc. | proteína de fusão do fator viii compreendendo polipeptídeo do fator viii fusionado a polipeptí-deo recombinante estendido (xten) e seu método de fabricação, ácido nucleico, vetores, célula hospedeira, bem como composição farmacêutica e seu uso no tratamento de coagulopatia, episódio de hemorragia e hemofilia a |
| CA2864126A1 (en) | 2012-02-15 | 2013-08-22 | Biogen Idec Ma Inc. | Recombinant factor viii proteins |
| US10548953B2 (en) | 2013-08-14 | 2020-02-04 | Bioverativ Therapeutics Inc. | Factor VIII-XTEN fusions and uses thereof |
| AU2015204646B2 (en) | 2014-01-10 | 2020-08-27 | Bioverativ Therapeutics Inc. | Factor VIII chimeric proteins and uses thereof |
| BR112018002150A2 (pt) | 2015-08-03 | 2018-09-18 | Bioverativ Therapeutics Inc | proteínas de fusão do fator ix e métodos de fabricação e uso das mesmas |
| KR102415992B1 (ko) | 2016-04-15 | 2022-07-04 | 다케다 야쿠힌 고교 가부시키가이샤 | 약물동역학 약물 투약 요법을 제공하는 방법 및 장치 |
| JP7618383B2 (ja) | 2016-07-22 | 2025-01-21 | ネクター セラピューティクス | オキシム含有リンケージを有する第ｖｉｉｉ因子部分のコンジュゲート |
| IL319473A (en) | 2016-12-02 | 2025-05-01 | Bioverativ Therapeutics Inc | Methods for treating hemophilic arthritis using chimeric blood clotting factors |
| US10896749B2 (en) | 2017-01-27 | 2021-01-19 | Shire Human Genetic Therapies, Inc. | Drug monitoring tool |
| US20200245667A1 (en) * | 2017-09-13 | 2020-08-06 | Evolve Biosystems, Inc. | Oligosaccharide compositions and their use during transitional phases of the mammalian gut microbiome |
| KR20190086269A (ko) * | 2018-01-12 | 2019-07-22 | 재단법인 목암생명과학연구소 | 체내 지속형 재조합 당단백질 및 이의 제조방법 |
| BR112020022164A2 (pt) | 2018-05-18 | 2021-02-02 | Bioverativ Therapeutics Inc. | métodos de tratamento de hemofilia a |
| US12252528B2 (en) * | 2018-10-23 | 2025-03-18 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating Factor VIII function |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6045849B2 (ja) | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4703008A (en) | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
| KR890002004B1 (ko) * | 1984-01-11 | 1989-06-07 | 가부시끼 가이샤 도오시바 | 지폐류 판별장치 |
| US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| US4970300A (en) * | 1985-02-01 | 1990-11-13 | New York University | Modified factor VIII |
| ATE72838T1 (de) | 1985-04-12 | 1992-03-15 | Genetics Inst | Neue prokoagulierungsproteine. |
| US5198349A (en) | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
| EP0254076B1 (en) * | 1986-07-11 | 1991-05-08 | Miles Inc. | Improved recombinant protein production |
| GB2197321B (en) | 1986-09-12 | 1990-10-03 | Genentech Inc | Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line |
| IL86693A (en) * | 1987-06-12 | 1994-06-24 | Stichting Centraal Lab | Proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| CA2075206C (en) * | 1989-12-01 | 2006-05-23 | Herbert L. Heyneker | Production of recombinant polypeptides by bovine species and transgenic methods |
| SE465222C5 (sv) | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
| US5661008A (en) | 1991-03-15 | 1997-08-26 | Kabi Pharmacia Ab | Recombinant human factor VIII derivatives |
| US5859204A (en) | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
| DE69433925T2 (de) * | 1993-06-10 | 2005-07-28 | Bayer Corp. | Vektoren und Zelllinien von Säugetieren mit erhöhter Produktivität |
| US5952198A (en) * | 1995-05-04 | 1999-09-14 | Bayer Corporation | Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
| DE19517194A1 (de) * | 1995-05-11 | 1996-11-14 | Giesecke & Devrient Gmbh | Vorrichtung und Verfahren zur Prüfung von Blattgut, wie z.B. Banknoten oder Wertpapiere |
| MX9504215A (es) | 1995-10-05 | 1997-04-30 | Inst Politecnico Nacional | Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica. |
| US5922959A (en) * | 1996-10-15 | 1999-07-13 | Currency Systems International | Methods of measuring currency limpness |
| US5923413A (en) * | 1996-11-15 | 1999-07-13 | Interbold | Universal bank note denominator and validator |
| US5804420A (en) * | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
| WO1999029848A1 (en) * | 1997-12-05 | 1999-06-17 | The Immune Response Corporation | Novel vectors and genes exhibiting increased expression |
| US6040584A (en) * | 1998-05-22 | 2000-03-21 | Mti Corporation | Method and for system for detecting damaged bills |
| US6528286B1 (en) | 1998-05-29 | 2003-03-04 | Genentech, Inc. | Mammalian cell culture process for producing glycoproteins |
| US6358703B1 (en) * | 1998-12-10 | 2002-03-19 | Bayer Corporation | Expression system for factor VIII |
| US6136599A (en) * | 1998-12-10 | 2000-10-24 | Bayer Corporation | Human hybrid host cell for mammalian gene expression |
| US6180108B1 (en) | 1998-12-10 | 2001-01-30 | Bayer Corporation | Vectors having terminal repeat sequence of Epstein-Barr virus |
-
1998
- 1998-12-10 US US09/209,916 patent/US6358703B1/en not_active Expired - Lifetime
-
1999
- 1999-08-12 UA UA2001074777A patent/UA77383C2/uk unknown
- 1999-12-08 TR TR2001/01592T patent/TR200101592T2/xx unknown
- 1999-12-08 CZ CZ20012024A patent/CZ302330B6/cs not_active IP Right Cessation
- 1999-12-08 DE DE69939839T patent/DE69939839D1/de not_active Expired - Lifetime
- 1999-12-08 RO ROA200100649A patent/RO121604B1/ro unknown
- 1999-12-08 BR BRPI9916069A patent/BRPI9916069B8/pt not_active IP Right Cessation
- 1999-12-08 JP JP2000586938A patent/JP4240818B2/ja not_active Expired - Lifetime
- 1999-12-08 RU RU2001119156/13A patent/RU2249041C2/ru active
- 1999-12-08 CA CA002354845A patent/CA2354845C/en not_active Expired - Lifetime
- 1999-12-08 PT PT99966068T patent/PT1137797E/pt unknown
- 1999-12-08 AU AU21701/00A patent/AU761801B2/en not_active Expired
- 1999-12-08 IL IL14335399A patent/IL143353A0/xx unknown
- 1999-12-08 DK DK99966068T patent/DK1137797T3/da active
- 1999-12-08 EP EP99966068A patent/EP1137797B1/en not_active Expired - Lifetime
- 1999-12-08 SI SI9920097A patent/SI20644B/sl active Search and Examination
- 1999-12-08 SK SK792-2001A patent/SK286945B6/sk not_active IP Right Cessation
- 1999-12-08 PL PL349284A patent/PL200676B1/pl unknown
- 1999-12-08 AT AT99966068T patent/ATE412765T1/de active
- 1999-12-08 ES ES99966068T patent/ES2315026T3/es not_active Expired - Lifetime
- 1999-12-08 HU HU0200558A patent/HU228489B1/hu unknown
- 1999-12-08 WO PCT/US1999/029169 patent/WO2000034505A1/en not_active Ceased
- 1999-12-08 KR KR1020017007149A patent/KR100616028B1/ko not_active Expired - Lifetime
- 1999-12-08 NZ NZ512234A patent/NZ512234A/xx not_active IP Right Cessation
-
2001
- 2001-05-24 IL IL143353A patent/IL143353A/en not_active IP Right Cessation
- 2001-06-01 NO NO20012718A patent/NO329544B1/no not_active IP Right Cessation
- 2001-06-06 BG BG105567A patent/BG65431B1/bg unknown
- 2001-12-06 US US10/006,091 patent/US20020102730A1/en not_active Abandoned
-
2002
- 2002-01-15 US US10/047,257 patent/US20020115152A1/en not_active Abandoned
- 2002-08-22 US US10/225,900 patent/US7459525B2/en not_active Expired - Fee Related
-
2007
- 2007-04-25 US US11/789,580 patent/US20090036358A1/en not_active Abandoned
-
2010
- 2010-11-08 US US12/941,685 patent/US8207117B2/en not_active Expired - Fee Related
-
2012
- 2012-05-29 US US13/482,326 patent/US8945869B2/en not_active Expired - Fee Related
-
2013
- 2013-06-14 US US13/918,053 patent/US9249209B2/en not_active Expired - Fee Related
-
2015
- 2015-12-30 US US14/985,134 patent/US9650431B2/en not_active Expired - Fee Related
-
2017
- 2017-04-05 US US15/480,162 patent/US20170267745A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1137797T3 (da) | Ekspressionssystem for faktor VIII | |
| AU4162400A (en) | Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii | |
| FI964172A7 (fi) | Geenin ilmentymisjärjestelmä in vivo | |
| LU91342I2 (fr) | Byetta-exénatide | |
| ITTO960078A0 (it) | Disposizione di fissaggio di guarniture in particolare minuteria per mobili. | |
| DE60120356D1 (de) | Verbesserte galactosylierung von rekombinanten proteinen | |
| DK0918059T3 (da) | Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater | |
| FI952574A0 (fi) | Glykosyylitransferaasiaktiiviset proteiinit | |
| NO308287B1 (no) | Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse | |
| EE9900297A (et) | Piimavalkude selektiivse lagundamise meetod teiste piimavalkude manulusel | |
| HUP0002985A2 (hu) | Glicirrizinsavat és legalább egy antivirális hatású proteint tartalmazó vírusellenes gyógyszerkészítmény | |
| EP1124850A4 (en) | 12 HUMAN SECRETED PROTEINS | |
| EP0851869A4 (en) | BREAST-SPECIFIC GENES AND PROTEINS | |
| DE60012713D1 (de) | Durch xanthurensäure modifizierte proteine | |
| ATE103141T1 (de) | Protein-hydrolyse. | |
| SE8502540L (sv) | Stabilt tandvardsmedel innehallande dextranas | |
| CA2032167A1 (en) | Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene | |
| FI913566A7 (fi) | Lisätty proteiinintuotanto eläimissä | |
| ATE262917T1 (de) | Präparation umfassend thiolgruppen-haltige proteine | |
| EP0652777A4 (en) | SMALL ANIMAL METASTASES MODEL. | |
| TR199600583A2 (tr) | Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi. | |
| ZA200007633B (en) | Pesticide preparations in the form of aqueous suspension. | |
| MX250271B (es) | Expresion de proteinas en hongos geneticamente modificados. | |
| ATE301713T1 (de) | Plazentaprotein 13 | |
| ID26903A (id) | Metode untuk menghasilkan protein terhidrolisis |